PLoS ONE · 2015 · 25 citations · 25 references
Life SciencesGeneticsNephrologyGenomicsMedical GeneticsPharmacogeneticsGenetic Risk AssessmentGenome-wide Association StudiesMolecular Risk FactorsGenomic Risk PredictionNephrotoxic InjuryNephrotoxic MedicationsPharmacogenomic Association StudiesSerum Creatinine AssessmentValidation In Diverse CohortsVancomycin NephrotoxicityVancomycin Toxicity
Vancomycin, a commonly used antibiotic, can be nephrotoxic. Known risk factors such as age, creatinine clearance, vancomycin dose / dosing interval, and concurrent nephrotoxic medications fail to accurately predict nephrotoxicity. To identify potential genomic risk factors, we performed a genome-wide association study (GWAS) of serum creatinine levels while on vancomycin in 489 European American individuals and validated findings in three independent cohorts totaling 439 European American individuals. In primary analyses, the chromosome 6q22.31 locus was associated with increased serum creatinine levels while on vancomycin therapy (most significant variant rs2789047, risk allele A, β = -0.06, p = 1.1 x 10(-7)). SNPs in this region had consistent directions of effect in the validation cohorts, with a meta-p of 1.1 x 10(-7). Variation in this region on chromosome 6, which includes the genes TBC1D32/C6orf170 and GJA1 (encoding connexin43), may modulate risk of vancomycin-induced kidney injury.
25
Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 51.7K citations · Full text
Inference of Population Structure Using Multilocus Genotype Data
Jonathan K. Pritchard, Matthew Stephens, Peter Donnelly · Genetics · 2000 · 34.3K citations · Full text
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Arif Khwaja · Nephron Clinical Practice · 2012 · 8K citations
Kidney International Supplements · 2012 · 4.3K citations · Full text